NDRA Endra Life Sciences Inc.

ENDRA Life Sciences Inc develops diagnostics and research products to improve the specificity of clinical ultrasound. Its products allow researchers and clinicians to generate images to identify and cure diseases.

$0.92
As of 11/30/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  06/30/2017
Outstanding shares:  42,165,726
Average volume:  371,875
Market cap:   $40,479,097
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    29273B104
ISIN:        US29273B1044
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   3.17
PS ratio:   0.00
Return on equity:   -78.88%
Net income %:   0.00%